Antonio Giordano, Clinical Director at Dana-Farber Cancer Institute, Assistant Professor at Harvard Medical School, shared a post on X:
“Join us for the Summit for Novel Therapeutics in Oncology and Precision Medicine in STOP Cancer 2026 where early clinical science, translational research, and collaboration come together to move new therapies forward for patients. ”
Other articles featuring Dr. Giordano on OncoDaily.